EPISODE · Apr 1, 2022 · 5 MIN
The Groundbreaking Approval of Tebentafusp for Uveal Melanoma With Richard Carvajal, MD
from Oncology Data Advisor · host i3 Health
In this interview, Dr. Richard Carvajal, Associate Professor of Medicine at Columbia University Irving Medical Center and editorial board member of Oncology Data Advisor, discusses the practice-changing significance of the approval of tebentafusp and delves further into future directions in the development of treatments for uveal melanoma.
What this episode covers
In this interview, Dr. Richard Carvajal, Associate Professor of Medicine at Columbia University Irving Medical Center and editorial board member of Oncology Data Advisor, discusses the practice-changing significance of the approval of tebentafusp and delves further into future directions in the development of treatments for uveal melanoma.
NOW PLAYING
The Groundbreaking Approval of Tebentafusp for Uveal Melanoma With Richard Carvajal, MD
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·2m
Jun 15, 2026 ·3m
Jun 14, 2026 ·2m
Jun 13, 2026 ·3m
Jun 12, 2026 ·3m
Jun 11, 2026 ·3m